Pfizer HER2 ExpressionTempus collaborates with Pfizer to further profile HER2 expression across various cancers.Apr 30, 2024Life SciencesCase StudyRelated contentArticleConstructing clinical timelines with line of therapyArticleDesigning smarter trials: A new model for clinical developmentArticleHow biotechs can build a data-driven R&D strategy